Tralgix Plus Tablets 37.5-325mg

  • No ratings yet

210.00

Tralgix PLUS (37.5mg/325mg) – Advanced Dual-Action Pain Relief

Tralgix PLUS is a powerful combination of Tramadol Hydrochloride and Paracetamol, designed for the management of moderate to severe pain. This dual-action formula works quickly to block pain signals and reduce discomfort, providing effective relief when standard painkillers aren’t enough.

Quantity

Category TABLETS (GENERAL) Share

Product Overview

Tralgix PLUS is a high-strength analgesic specifically formulated to tackle stubborn pain. By combining the opioid strength of Tramadol with the proven efficacy of Paracetamol, it offers a synergistic effect that provides faster and more prolonged relief than either ingredient alone.

Key Benefits

  • Dual-Action Formula: Combines two active ingredients to target pain through different pathways in the body.

  • Moderate to Severe Pain Relief: Effective for acute pain, post-surgical recovery, and chronic musculoskeletal discomfort.

  • Film-Coated Tablets: Designed for easy swallowing and consistent absorption.

  • Quality Assured: Manufactured by Evolution Pharmaceuticals in an ISO Certified facility.

Technical Specifications

  • Composition: Each film-coated tablet contains:

    • Tramadol Hydrochloride (U.S.P.): 37.5mg

    • Paracetamol (U.S.P.): 325mg

  • Pack Size: 10 Film-coated tablets.

  • Regulatory: Registered under Reg. No. 095404.

Dosage & Administration

  • Dosage: As strictly directed by your physician.

  • Instructions: Do not exceed the recommended dose. Refer to the package insert for full prescribing information.

Storage & Safety

  • Storage: Store below 30°C. Protect from heat, moisture, and direct sunlight.

  • Warning: This is a prescription-only medicine. Keep all medicines out of the reach and sight of children.

  • Precautions: Consult your doctor regarding potential side effects or if you have a history of respiratory or liver issues.

There are no reviews yet.

Add a Review

Your email address will not be published. Required fields are marked *